Dr. Guojun Bu, associate director of the Mayo Clinic Center for Regenerative Medicine, explains how new U.S. Food and Drug Administration approval clears the way for Mayo Clinic to accelerate production of stem cells for clinical trials.
Dr. Guojun Bu, associate director of the Mayo Clinic Center for Regenerative Medicine, explains how new U.S. Food and Drug Administration approval clears the way for Mayo Clinic to accelerate production of stem cells for clinical trials.